SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000728889-16-002223
Filing Date
2016-02-05
Accepted
2016-02-05 15:26:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G clovisoncology13ga.htm SC 13G/A 20341
  Complete submission text file 0000728889-16-002223.txt   22169
Mailing Address TWO WORLD FINANCIAL CENTER 225 LIBERTY STREET NEW YORK NY 10281-1008
Business Address TWO WORLD FINANCIAL CENTER 225 LIBERTY STREET NEW YORK NY 10281-1008 212-323-0200
OppenheimerFunds, Inc. (Filed by) CIK: 0000728889 (see all company filings)

IRS No.: 000000000 | State of Incorp.: CO | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000

Mailing Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301
Business Address 5500 FLATIRON PARKWAY SUITE 100 BOULDER CO 80301 (303) 625-5000
Clovis Oncology, Inc. (Subject) CIK: 0001466301 (see all company filings)

IRS No.: 900475355 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86488 | Film No.: 161391982
SIC: 2834 Pharmaceutical Preparations